Loading patent…
AssigneeState of Oregon acting by and through the State Board of Higher Education on behalf of Oregon State University
InventorsDaniel D. Rockey, John P. Bannantine
Estimating the term…
Certain Chlamydia proteins have been found to be infection-specific and to be associated primarily with the vegetative Reticulate Body form of Chlamydia rather than with the refractile Elementary Body form of Chlamydia. The invention includes a vaccine directed against the Reticulate Body form of Chlamydia comprising one or more infection-specific proteins, or fraction thereof; a method of using such a vaccine; a method of production of such a vaccine; a method for detection of infection-specific antibodies in a biological specimen; a method for detection of infection-specific antigens in a biological specimen and a method of using therapeutic agents specifically directed against infection-specific peptides, or the genes that code for such peptides, to treat chlamydial infection. The invention also includes the IncB, and IncC proteins of C. psittaci, and nucleotides encoding these proteins, ant the TroA, TroB and p242 proteins of C. trachomatis, and the nucleotides that encode polypeptides.
A composition for inducing an immune response in a subject, comprising two purified peptides wherein a first peptide comprises at least 10 contiguous amino acids of the amino acid sequence as set forth as SEQ ID NO:
A composition for inducing an immune response comprising two purified peptides wherein the first peptide comprises the amino acid sequence as set forth as SEQ ID NO:
A method of making a composition for inducing an immune response in a mammal comprising combining a pharmaceutically acceptable excipient with two purified peptides wherein a first peptide comprises the amino acid sequence as set forth as SEQ ID NO:
A composition for inducing an immune response in a subject, comprising at least one purified peptide comprising at least 10 contiguous amino acids of the amino acid sequence set forth as SEQ ID NO:
A method of making a composition for inducing an immune response in a mammal comprising combining a pharmaceutically acceptable excipient with at least one purified peptide comprising at least 10 contiguous amino acid residues of the amino acid sequence set forth as SEQ ID NO:
Dependencies are inferred from the claim text.